glp 1 approved for heart disease GLP-1 Medications & Health Medicare to cover Wegovy when

doi: 10.1111/obr.13428 35 WildingJPHBatterhamRLCalannaSDaviesMVan GaalLFLingvayIet al

However, healthcare professionals A GLP-1 agonist might also be recommended for people who are unable to meet their blood sugar goals using other medications or those with a HbA1c level at least 1.5% above their target

Effects of sitagliptin on coronary atherosclerosis in patients with type 2 diabetes-A serial integrated backscatter-intravascular ultrasound study

For most patients, this is at the 20-week mark

However, the extent to which these benefits are truly independent of weight loss may differ by condition, and more research is needed to clarify these relationships